Harnessing neoantigen specific CD4 T cells for cancer immunotherapy

被引:49
作者
Brightman, Spencer E. [1 ]
Naradikian, Martin S. [1 ]
Miller, Aaron M. [1 ]
Schoenberger, Stephen P. [1 ]
机构
[1] La Jolla Inst Immunol, 9420 Athena Circle, La Jolla, CA 92037 USA
关键词
adoptive cell therapy; cancer vaccines; immune checkpoint blockade; neoantigens; TUMOR-INFILTRATING LYMPHOCYTES; EXOME ANALYSIS REVEALS; DENDRITIC CELLS; CTLA-4; BLOCKADE; PEPTIDE VACCINATION; ANTITUMOR-ACTIVITY; PD-1; B-CELL; CD8(+); ANTIGEN;
D O I
10.1002/JLB.5RI0220-603RR
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The goal of precision immunotherapy is to direct a patient's T cell response against the immunogenic mutations expressed on their tumors. Most immunotherapy approaches to-date have focused on MHC class I-restricted peptide epitopes by which cytotoxic CD8(+) T lymphocytes (CTL) can directly recognize tumor cells. This strategy largely overlooks the critical role of MHC class II-restricted CD4(+) T cells as both positive regulators of CTL and other effector cell types, and as direct effectors of antitumor immunity. In this review, we will discuss the role of neoantigen specific CD4(+) T cells in cancer immunotherapy and how existing treatment modalities may be leveraged to engage this important T cell subset.
引用
收藏
页码:625 / 633
页数:9
相关论文
共 126 条
[1]   Defining HLA-II Ligand Processing and Binding Rules with Mass Spectrometry Enhances Cancer Epitope Prediction [J].
Abelin, Jennifer G. ;
Harjanto, Dewi ;
Malloy, Matthew ;
Suri, Prerna ;
Colson, Tyler ;
Goulding, Scott P. ;
Creech, Amanda L. ;
Serrano, Lia R. ;
Nasir, Gibran ;
Nasrullah, Yusuf ;
McGann, Christopher D. ;
Velez, Diana ;
Ting, Ying S. ;
Poran, Asaf ;
Rothenberg, Daniel A. ;
Chhangawala, Sagar ;
Rubinsteyn, Alex ;
Hammerbacher, Jeff ;
Gaynor, Richard B. ;
Fritsch, Edward F. ;
Greshock, Joel ;
Oslund, Rob C. ;
Barthelme, Dominik ;
Addona, Terri A. ;
Arleta, Christina M. ;
Rooney, Michael S. .
IMMUNITY, 2019, 51 (04) :766-+
[2]   CD4+ T Cell Help Confers a Cytotoxic T Cell Effector Program Including Coinhibitory Receptor Downregulation and Increased Tissue Invasiveness [J].
Ahrends, Tomasz ;
Spanjaard, Aldo ;
Pilzecker, Bas ;
Babala, Nikolina ;
Bovens, Astrid ;
Xiao, Yanling ;
Jacobs, Heinz ;
Borst, Jannie .
IMMUNITY, 2017, 47 (05) :848-+
[3]   DEVELOPMENT OF HIGH POTENCY UNIVERSAL DR-RESTRICTED HELPER EPITOPES BY MODIFICATION OF HIGH-AFFINITY DR-BLOCKING PEPTIDES [J].
ALEXANDER, J ;
SIDNEY, J ;
SOUTHWOOD, S ;
RUPPERT, J ;
OSEROFF, C ;
MAEWAL, A ;
SNOKE, K ;
SERRA, HM ;
KUBO, RT ;
SETTE, A ;
GREY, HM .
IMMUNITY, 1994, 1 (09) :751-761
[4]   Signatures of mutational processes in human cancer [J].
Alexandrov, Ludmil B. ;
Nik-Zainal, Serena ;
Wedge, David C. ;
Aparicio, Samuel A. J. R. ;
Behjati, Sam ;
Biankin, Andrew V. ;
Bignell, Graham R. ;
Bolli, Niccolo ;
Borg, Ake ;
Borresen-Dale, Anne-Lise ;
Boyault, Sandrine ;
Burkhardt, Birgit ;
Butler, Adam P. ;
Caldas, Carlos ;
Davies, Helen R. ;
Desmedt, Christine ;
Eils, Roland ;
Eyfjord, Jorunn Erla ;
Foekens, John A. ;
Greaves, Mel ;
Hosoda, Fumie ;
Hutter, Barbara ;
Ilicic, Tomislav ;
Imbeaud, Sandrine ;
Imielinsk, Marcin ;
Jaeger, Natalie ;
Jones, David T. W. ;
Jones, David ;
Knappskog, Stian ;
Kool, Marcel ;
Lakhani, Sunil R. ;
Lopez-Otin, Carlos ;
Martin, Sancha ;
Munshi, Nikhil C. ;
Nakamura, Hiromi ;
Northcott, Paul A. ;
Pajic, Marina ;
Papaemmanuil, Elli ;
Paradiso, Angelo ;
Pearson, John V. ;
Puente, Xose S. ;
Raine, Keiran ;
Ramakrishna, Manasa ;
Richardson, Andrea L. ;
Richter, Julia ;
Rosenstiel, Philip ;
Schlesner, Matthias ;
Schumacher, Ton N. ;
Span, Paul N. ;
Teague, Jon W. .
NATURE, 2013, 500 (7463) :415-+
[5]   Migratory dendritic cells transfer antigen to a lymph node-resident dendritic cell population for efficient CTL priming [J].
Allan, Rhys S. ;
Waithman, Jason ;
Bedoui, Sammy ;
Jones, Claerwen M. ;
Villadangos, Jose A. ;
Zhan, Yifan ;
Lew, Andrew M. ;
Shortman, Ken ;
Heath, William R. ;
Carbone, Francis R. .
IMMUNITY, 2006, 25 (01) :153-162
[6]   MHC-II neoantigens shape tumour immunity and response to immunotherapy [J].
Alspach, Elise ;
Lussier, Danielle M. ;
Miceli, Alexander P. ;
Kizhvatov, Ilya ;
DuPage, Michel ;
Luoma, Adrienne M. ;
Meng, Wei ;
Lichti, Cheryl F. ;
Esaulova, Ekaterina ;
Vomund, Anthony N. ;
Runci, Daniele ;
Ward, Jeffrey P. ;
Gubin, Matthew M. ;
Medrano, Ruan F. V. ;
Arthur, Cora D. ;
White, J. Michael ;
Sheehan, Kathleen C. F. ;
Chen, Alex ;
Wucherpfennig, Kai W. ;
Jacks, Tyler ;
Unanue, Emil R. ;
Artyomov, Maxim N. ;
Schreiber, Robert D. .
NATURE, 2019, 574 (7780) :696-+
[7]   Germinal centers: programmed for affinity maturation and antibody diversification [J].
Bannard, Oliver ;
Cyster, Jason G. .
CURRENT OPINION IN IMMUNOLOGY, 2017, 45 :21-30
[8]   Vaccination of stage III/IV melanoma patients with long NY-ESO-1 peptide and CpG-B elicits robust CD8+ and CD4+ T-cell responses with multiple specificities including a novel DR7-restricted epitope [J].
Baumgaertner, P. ;
Nunes, C. Costa ;
Cachot, A. ;
Maby-El Hajjami, H. ;
Cagnon, L. ;
Braun, M. ;
Derre, L. ;
Rivals, J. -P. ;
Rimoldi, D. ;
Gnjatic, S. ;
Abed Maillard, S. ;
Marcos Mondejar, P. ;
Protti, M. P. ;
Romano, E. ;
Michielin, O. ;
Romero, P. ;
Speiser, D. E. ;
Jandus, C. .
ONCOIMMUNOLOGY, 2016, 5 (10)
[9]   Dual PD-1 and CTLA-4 Checkpoint Blockade Promotes Antitumor Immune Responses through CD4+Foxp3- Cell-Mediated Modulation of CD103+ Dendritic Cells [J].
Beavis, Paul A. ;
Henderson, Melissa A. ;
Giuffrida, Lauren ;
Davenport, Alexander J. ;
Petley, Emma V. ;
House, Imran G. ;
Lai, Junyun ;
Sek, Kevin ;
Milenkovski, Nicole ;
John, Liza B. ;
Mardiana, Sherly ;
Slaney, Clare Y. ;
Trapani, Joseph A. ;
Loi, Sherene ;
Kershaw, Michael H. ;
Haynes, Nicole M. ;
Darcy, Phillip K. .
CANCER IMMUNOLOGY RESEARCH, 2018, 6 (09) :1069-1081
[10]   Help for cytotoxic-T-cell responses is mediated by CD40 signalling [J].
Bennett, SRM ;
Carbone, FR ;
Karamalis, F ;
Flavell, RA ;
Miller, JFAP ;
Heath, WR .
NATURE, 1998, 393 (6684) :478-480